VERAXA Biotech GmbH

📍 Heidelberg, Germany👥 38 employees💰 Last funded May 2021
Biotechnology Research🌐 veraxa.com
Website LinkedIn
VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation. Through biochemical and technological innovation, we strive to transform the way antibodies and antibody-drug conjugates (ADCs) are created to develop more effective and safe therapies for patients. With our transformative technologies, we can streamline and derisk early bioconjugate development. We have established a rich pipeline of proprietary ADCs and are collaborating with a number of partners to provide access to our unique research & development capabilities going from target to antibody to ADC.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Arab Emirates
1
Frequently asked questions
Who invested in VERAXA Biotech GmbH?
VERAXA Biotech GmbH has 1 investors on record on gritt.io.
When did VERAXA Biotech GmbH last raise funding?
The most recent investment in VERAXA Biotech GmbH recorded on gritt.io was in May 2021.
What industry is VERAXA Biotech GmbH in?
VERAXA Biotech GmbH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is VERAXA Biotech GmbH based?
VERAXA Biotech GmbH is headquartered in Heidelberg, Germany.